The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Oldogg
you got another one now
https://www.proactiveinvestors.co.uk/companies/news/1016232/creo-medical-group-really-pleased-with-first-human-trial-of-lung-lesion-treatment-1016232.html
Thanks for that Troajan.
Great news for CREO that their microwave ablation tool has been used against lung cancer lesions for the first time on a patient. Apparently this trial has been made possible by new screening techniques, a game changer in the fight against lung cancer. Potentially, this technology could obviate the need for chemotherapy and radiation for some patients. Congrats to all involved, especially heroic doctors at Royal Brompton Hospital
Sorry 1eyed, I completely missed that, even with two good eyes ( :
Yes, long termers here are possibly underwater and 'waving', but for new investors it could become a shiny speedboat
Sorry my wording was bad in my post. I was referring to a couple of £10k share buys which is pretty chunky as volumes are pretty thin. But I agree the ongoing revenue from sales from hospitals embracing the devices is encouraging.
The significance is how they've gone all in, very quickly, clearly seeing CREO's system as MUCH better than old methods in every respect - so not just a buy, but ongoing revenue. Assuming they successfully save money while improving patient outcomes, it seems like a no-brainer for lots of others to follow fairly swiftly?
A lot of work to do to get more hospitals on board with the devices but so far so good. Couple of fairly decent buys someone likes it.
Nice to see the company heading in the right direction 👍
Known this company since its inception as Microoncology. Extreme talent will be a longer-term investment. Not for the city quick buck brigade!
Another useful link-thank you. Nice to see the last raise confidently referred to as 'final', although it risks something of a credibility issue should this not prove to be the case.
@Faicj -Welcome and GL I hope you make lots of money :).
https://www.proactiveinvestors.co.uk/companies/news/1014104/creo-medical-group-knows-what-it-needs-to-do-after-terrific-2022-1014104.html
1eyedman
getting a mine in production,is a nightmare.
loads fail,because for whatever reason,tonnages/recovery rates....cant be achieved
rmm,failed,just recently.....and capex costs,are off the scale,$100 million,gets you a small mine nowarday
Just bought in here today, and been with eml not to long so can wait a bit
Potash was a good bet for me and the value of potash increased when fertilisers became short. There was just one tiny tiny problem which was the plant to process the extraction did not work as designed. The big lenders had first call on the considerable infrastructure that has been built (after several placings etc.) so I guess it was a no brainer to them to turn off the financial taps and let the company fail. I have to agree that Australian CEO's seem to have more than their fair share of bad luck shall we say :).
At least here we have products already for sale and we just have to hope for further sales and successful use of the products. I should have learnt some time ago from my experience with gold miners, the only ones who have earnt me a bit of profit are ones that were already producing before I bought in (as opposed to being a hopeful hole in the ground). Mind you I mustn't get too enthusiastic or Ill end up buying some more CREO when I get some 'spare' cash.
cheers 1eyedman
you mean so4 and yeah,think they did some nasty big placings aswell.
potash?...eml..that ones done real well and still going strong,dunno the funding debt situation.
harvest minerals aswell.
neither have australian ceo's.lol.
Troajan
Yes it’s odd. Mind you when it was clear that my last AIM investment was going to go under quite a few obvious rampers appeared which pretty disappointing. Another one I had and sold was a miner endlessly waiting for a licence, I did not post on that board but sometimes check in and the same people are there years later still waiting for the licence. Very civilised around here though!.
Gl yourself
1eyedman
i see it all over,some great comps and no one posts,on them.
then you get other comps,dodgy as heck and the boards,overflowing.
odd that.lol.
gl
“A very busy board” :). It’s quality that counts.
Appreciate the links though.
https://www.proactiveinvestors.co.uk/companies/news/1013470/creo-medical-powers-on-towards-profitability-1013470.html
a very busy boatd this.
Agreed, positive forward looking RNS. For balance though the elephant in the room is the yearly loss. This will need to turn round pretty fast to avoid further dilution. No deal breakers though which is a good start!.
GL
Good rns and things sound upbeat and positive , looking forward to seeing how things progress
Good luck all
John
Interesting and informative RNS. It may not have much immediate effect on SP as the studies look pretty long term which I guess is to be expected. It would be excellent if the device proves to be effective for issues not currently eligible for surgery (from RNS). From a human perspective I mean in this instance. What a useful tech this could turn out to be.